SCHEMBL3262963

SCHEMBL3262963

COC(=O)CNC(=O)c1ccc(Cc2c(O)c3ccccc3oc2=O)cc1

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
VKORC1 Q9BQB6 8/20 0.64
NQO1 P15559 7/20 0.59
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
ALDH1A1 P00352 2/20 0.54
ABCB11 O95342 1/20 0.54
LMNA P02545 1/20 0.54
TP53 P04637 1/20 0.54
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2C9 P11712 1/20 0.54
TSHR P16473 1/20 0.54
MAPK1 P28482 1/20 0.54
CYP2C19 P33261 1/20 0.54
PDE4D Q08499 1/20 0.54
PCSK7 Q16549 1/20 0.54
GPR35 Q9HC97 1/20 0.54
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3480712 0.88 NQO1 (0.67) VKORC1NQO1MEN1KMT2AALDH1A1
SCHEMBL1648184 0.84 VKORC1 (0.72) VKORC1NQO1MEN1KMT2AALDH1A1
SCHEMBL3177583 0.82 VKORC1 (0.69) VKORC1NQO1MEN1KMT2AALDH1A1
SCHEMBL3166280 0.82 VKORC1 (0.62) VKORC1NQO1MEN1KMT2AALDH1A1
SCHEMBL13498415 0.81 NQO1 (0.72) VKORC1NQO1MEN1KMT2AALDH1A1
SCHEMBL3171705 0.80 VKORC1 (0.59) VKORC1NQO1MEN1KMT2AALDH1A1
SCHEMBL1647685 0.80 VKORC1 (0.65) VKORC1NQO1MEN1KMT2AALDH1A1
SCHEMBL1649892 0.79 NQO1 (0.79) VKORC1NQO1MEN1KMT2AALDH1A1
SCHEMBL29655586 0.79 NQO1 (0.79) VKORC1NQO1MEN1KMT2AALDH1A1
SCHEMBL4589169 0.78 VKORC1 (0.59) VKORC1NQO1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161261-B1 Materials and methods for treating coagulation disorders ARMETHEON INC (US) 2013-08-28 EP disclosed
EP-2161261-A1 Materials and methods for treating coagulation disorders Aryx Therapeutics (US) 2010-03-10 EP disclosed